Getty Images
A recent Yahoo! Finance article discussed the latest 10-figure deal in pharmaceutical packaging. Germany's Schott Pharma has secured contracts worth approximately $1 billion to supply glass cartridges and syringes to leading companies in the GLP-1 drug class, catering to diabetes and weight-loss drugs. Schott’s CEO, Andreas Reisse, announced these contracts during the company's IPO launch event, highlighting the significance of GLP-1 drugs in the pharmaceutical industry.
